Identification of cross-stage, cross-species malaria CD8⁺ T cell antigens

World Health Organization. World Malaria Report 2025: Addressing the Threat of Antimalarial Drug Resistance (WHO, 2025). Leong, Y. W., Russell, B., Malleret, B. & Renia, L. Erythrocyte tropism of malarial parasites: the reticulocyte appeal. Front. Microbiol. 13 , 1022828 (2022). Article PubMed PubMed Central Google Scholar Junqueira, C. et al. Cytotoxic CD8 + T cells recognize and kill Plasmodium vivax -infected reticulocytes. Nat. Med. 24 , 1330–1336 (2018). Article CAS PubMed PubMed Central Google Scholar Kurtovic, L. et al. Induction and decay of functional complement-fixing antibodies by the RTS,S malaria vaccine in children, and a negative impact of malaria exposure. BMC Med. 17 , 45 (2019). Article PubMed PubMed Central Google Scholar Duffy, P. E. Current approaches to malaria vaccines. Curr. Opin. Microbiol. 70 , 102227 (2022). Article CAS PubMed PubMed Central Google Scholar Richie, T. L. et al. Sporozoite immunization: innovative translational science to support the fight against malaria. Expert Rev. Vaccines 22 , 964–1007 (2023). Article CAS PubMed PubMed Central Google Scholar Moorthy, V., Hamel, M. J. & Smith, P. G. Malaria vaccines for children: and now there are two. Lancet 403 , 504–505 (2024). Article PubMed Google Scholar White, M. T. et al. Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial. Lancet Infect. Dis. 15 , 1450–1458 (2015). …